Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-CD163L1 (350-550) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:200-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
CD163L1 |
Gene ID: |
283316 |
Uniprot ID: |
C163B_HUMAN |
Immunogen Region: |
350-550 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 350-550 of human CD163L1 (NP_777601.2). |
Immunogen Sequence: |
DCLHQNDVSVICSDGADLEL RLADGSNNCSGRVEVRIHEQ WWTICDQNWKNEQALVVCKQ LGCPFSVFGSRRAKPSNEAR DIWINSISCTGNESALWDCT YDGKAKRTCFRRSDAGVICS DKADLDLRLVGAHSPCYGRL EVKYQGEWGTVCHDRWSTRN AAVVCKQLGCGKPMHVFGMT YFKEASGPIWLDDVSCIGNE S |
Tissue Specificity | Isoform 1 is highly expressed in the spleen, lymph nodes, thymus, and fetal liver and weakly expressed in bone marrow and no expression was found in peripheral blood leukocytes. Isoform 1 expression is restricted to the monocyte and macrophage cell lines. Isoform 2 is only expressed in spleen. |
Protein Name | Scavenger Receptor Cysteine-Rich Type 1 Protein M160Cd163 Antigen-Like 1Cd Antigen Cd163b |
Cellular Localisation | Isoform 1: Cell MembraneSingle-Pass Type I Membrane ProteinIsoform 2: Cell MembraneIsoform 3: Secreted |
Alternative Antibody Names | Anti-Scavenger Receptor Cysteine-Rich Type 1 Protein M160 antibodyAnti-Cd163 Antigen-Like 1 antibodyAnti-Cd Antigen Cd163b antibodyAnti-CD163L1 antibodyAnti-CD163B antibodyAnti-M160 antibodyAnti-UNQ6434 antibodyAnti-PRO23202 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance